levomilnacipran

Levomilnacipran (F2696; (1R,2S)-milnacipran) is the enantiomer of milnacipran and acts as a selective serotonin and norepinephrine (5-HT/NE) reuptake inhibitor. It also serves as a human α-adrenergic receptor antagonist with an IC50 of 3.4 μM, as detailed in patent WO2013014263A1.

Milnacipran (1S-cis) hydrochloride (Levomilnacipran Hydrochloride) is a serotonin-norepinephrine reuptake inhibitor (SNRI), treatment of fibromyalgia.

Dextromilnacipran (Levomilnacipran) is a selective serotonin and norepinephrine reuptake inhibitor.

Milnacipran-D10 hydrochloride is a deuterated compound of Milnacipran Hydrochloride. Milnacipran Hydrochloride (T1189) has a CAS number of 101152-94-7. Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantiomer of milnacipran, which is used to treat fibromyalgia. Levomilnacipran and milnacipran have been associated with a low rate of transient elevations in serum aminotransferase levels during treatment and with rare instances of clinically apparent acute liver injury with jaundice.

Milnacipran-D10 Hydrochloride (Standard) is a reference standard of Milnacipran-D10 Hydrochloride intended for quantitative analysis, quality control, and related biochemical research applications. Milnacipran-d10 Hydrochloride is a deuterated compound of Milnacipran Hydrochloride. Milnacipran Hydrochloride has a CAS number of 101152-94-7. Levomilnacipran is a serotonin and norepinephrine reuptake inhibitor used to treat major depressive disorders. Levomilnacipran is an enantiomer of milnacipran, which is used to treat fibromyalgia. Levomilnacipran and milnacipran have been associated with a low rate of transient elevations in serum aminotransferase levels during treatment and with rare instances of clinically apparent acute liver injury with jaundice.